End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
19.28
CNY
|
+2.61%
|
|
-0.87%
|
-12.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
18,516
|
50,574
|
60,083
|
37,451
|
37,216
|
32,394
|
-
|
-
|
Enterprise Value (EV)
1 |
18,516
|
50,574
|
60,083
|
37,451
|
37,216
|
32,394
|
32,394
|
32,394
|
P/E ratio
|
27.6
x
|
97.1
x
|
85.1
x
|
40.5
x
|
29.9
x
|
21.5
x
|
17.4
x
|
16.3
x
|
Yield
|
-
|
0.31%
|
0.36%
|
0.74%
|
1.01%
|
1.14%
|
1.43%
|
1.14%
|
Capitalization / Revenue
|
7.49
x
|
17.4
x
|
15.8
x
|
8.42
x
|
7.79
x
|
6.25
x
|
4.69
x
|
4.57
x
|
EV / Revenue
|
7.49
x
|
17.4
x
|
15.8
x
|
8.42
x
|
7.79
x
|
6.25
x
|
4.69
x
|
4.57
x
|
EV / EBITDA
|
20.3
x
|
78.1
x
|
69.2
x
|
36.5
x
|
27.5
x
|
21.5
x
|
16.7
x
|
14.6
x
|
EV / FCF
|
-
|
-
|
219,725,324
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.67
x
|
9.58
x
|
12.4
x
|
5.71
x
|
4.95
x
|
3.76
x
|
3.27
x
|
2.77
x
|
Nbr of stocks (in thousands)
|
1,680,185
|
1,680,185
|
1,680,185
|
1,680,185
|
1,680,185
|
1,680,185
|
-
|
-
|
Reference price
2 |
11.02
|
30.10
|
35.76
|
22.29
|
22.15
|
19.28
|
19.28
|
19.28
|
Announcement Date
|
3/15/20
|
3/15/21
|
3/15/22
|
3/15/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,473
|
2,912
|
3,808
|
4,446
|
4,780
|
5,183
|
6,901
|
7,092
|
EBITDA
1 |
913.2
|
647.5
|
868.6
|
1,025
|
1,353
|
1,510
|
1,941
|
2,216
|
EBIT
1 |
664.5
|
510.3
|
705.1
|
891
|
1,212
|
1,357
|
1,805
|
1,945
|
Operating Margin
|
26.86%
|
17.53%
|
18.52%
|
20.04%
|
25.36%
|
26.18%
|
26.16%
|
27.43%
|
Earnings before Tax (EBT)
1 |
667.5
|
516.5
|
705.8
|
893.6
|
1,213
|
1,358
|
1,808
|
1,947
|
Net income
1 |
551.6
|
430.9
|
591.4
|
765.3
|
1,031
|
1,149
|
1,542
|
1,648
|
Net margin
|
22.3%
|
14.8%
|
15.53%
|
17.21%
|
21.58%
|
22.17%
|
22.35%
|
23.23%
|
EPS
2 |
0.4000
|
0.3100
|
0.4200
|
0.5500
|
0.7400
|
0.8962
|
1.107
|
1.183
|
Free Cash Flow
|
-
|
-
|
273.4
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
7.18%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
31.48%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
46.24%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0930
|
0.1280
|
0.1650
|
0.2230
|
0.2200
|
0.2750
|
0.2200
|
Announcement Date
|
3/15/20
|
3/15/21
|
3/15/22
|
3/15/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
273
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
13.8%
|
10.1%
|
12.7%
|
14.9%
|
17.7%
|
15.9%
|
18.2%
|
16.9%
|
ROA (Net income/ Total Assets)
|
7.76%
|
6.6%
|
8.8%
|
10.5%
|
-
|
12.3%
|
14.3%
|
13.8%
|
Assets
1 |
7,111
|
6,533
|
6,724
|
7,275
|
-
|
9,319
|
10,782
|
11,974
|
Book Value Per Share
2 |
3.000
|
3.140
|
2.880
|
3.900
|
4.480
|
5.130
|
5.910
|
6.950
|
Cash Flow per Share
2 |
0.6800
|
0.1100
|
0.2700
|
0.3000
|
0.3100
|
0.6300
|
0.6000
|
0.7900
|
Capex
1 |
174
|
91.4
|
108
|
245
|
229
|
230
|
288
|
401
|
Capex / Sales
|
7.05%
|
3.14%
|
2.85%
|
5.5%
|
4.8%
|
4.43%
|
4.17%
|
5.65%
|
Announcement Date
|
3/15/20
|
3/15/21
|
3/15/22
|
3/15/23
|
3/15/24
|
-
|
-
|
-
|
Last Close Price
19.28
CNY Average target price
27.94
CNY Spread / Average Target +44.92% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.96% | 4.47B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|